Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' Younossi, ZM' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 63 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Ong, J; Younossi, ZM; Reddy, V; Price, LL; Gramlich, T; Mayes, J; Boparai, N
      Cryptogenic cirrhosis and posttransplantation nonalcoholic fatty liver disease

      LIVER TRANSPLANTATION
    2. Falck-Ytter, Y; Younossi, ZM; Marchesini, G; McCullough, AJ
      Clinical features and natural history of nonalcoholic steatosis syndromes

      SEMINARS IN LIVER DISEASE
    3. Hadziyannis, E; Hadziyannis, A; Yen-Lieberman, B; Kiwi, ML; Hodnick, S; Spanou, F; Starkey, C; Younossi, ZM
      Hepatitis C virus RNA assays - A comparison of SuperQuant and Monitor

      JOURNAL OF CLINICAL GASTROENTEROLOGY
    4. Younossi, ZM; Mullen, KD; Zakko, W; Hodnick, S; Brand, E; Barnes, DS; Carey, WD; McCullough, AC; Easley, K; Boparai, N; Gramlich, T
      A randomized, double-blind controlled trial of interferon alpha-2b and ribavirin vs. interferon alpha-2b and amantadine for treatment of chronic hepatitis C non-responder to interferon monotherapy

      JOURNAL OF HEPATOLOGY
    5. Ong, JP; Younossi, ZM; Speer, C; Olano, A; Gramlich, T; Boparai, N
      Chronic hepatitis C and superimposed nonalcoholic fatty liver disease

      LIVER
    6. Ong, JP; Younossi, ZM; Gramlich, T; Goodman, Z; Mayes, J; Sarbah, S; Yen-Lieberman, B
      Interferon alpha 2B and ribavirin in severe recurrent cholestatic hepatitis C

      TRANSPLANTATION
    7. Younossi, ZM
      Chronic liver disease and health-related quality of life

      GASTROENTEROLOGY
    8. Aggarwal, A; Ong, JP; Younossi, ZM; Nelson, DR; Hoffman-Hogg, L; Arroliga, AC
      Predictors of mortality and resource utilization in cirrhotic patients admitted to the medical ICU

      CHEST
    9. Shen, B; Younossi, ZM; Dolmatch, B; Newman, JS; Henderson, JM; Ong, JP; Gramlich, T; Yamani, M
      Patent ductus venosus in an adult presenting as pulmonary hypertension, right-sided heart failure, and portosystemic encephalopathy

      AMERICAN JOURNAL OF MEDICINE
    10. Mendez, P; Saeian, K; Reddy, KR; Younossi, ZM; Kerdel, F; Badalamenti, S; Jeffers, LJ; Schiff, ER
      Hepatitis C, cryoglobulinemia, and cutaneous vasculitis associated with unusual and serious manifestations

      AMERICAN JOURNAL OF GASTROENTEROLOGY
    11. Younossi, ZM; Boparai, N; Price, LL; Kiwi, ML; McCormick, M; Guyatt, G
      Health-related quality of life in chronic liver disease: The impact of type and severity of disease

      AMERICAN JOURNAL OF GASTROENTEROLOGY
    12. Younossi, ZM; Boparai, N; McCormick, M; Price, LL; Guyatt, G
      Assessment of utilities and health-related quality of life in patients with chronic liver disease

      AMERICAN JOURNAL OF GASTROENTEROLOGY
    13. Broussard, CN; Aggarwal, A; Lacey, SR; Post, AB; Gramlich, T; Henderson, JM; Younossi, ZM
      Mushroom poisoning - From diarrhea to liver transplantation

      AMERICAN JOURNAL OF GASTROENTEROLOGY
    14. Younossi, ZM; McCormick, M; Price, LL; Boparai, N; Farquhar, L; Henderson, JM; Guyatt, G
      Impact of liver transplantation on health-related quality of life

      LIVER TRANSPLANTATION
    15. Saadeh, S; Younossi, ZM
      The spectrum of nonalcoholic fatty liver disease: From steatosis to nonalcoholic steatohepatitis

      CLEVELAND CLINIC JOURNAL OF MEDICINE
    16. Younossi, ZM
      Viral hepatitis guide for practicing physicians

      CLEVELAND CLINIC JOURNAL OF MEDICINE
    17. Zdilar, D; Franco-Bronson, K; Buchler, N; Locala, JA; Younossi, ZM
      Hepatitis C, interferon alfa, and depression

      HEPATOLOGY
    18. Younossi, ZM; Singer, ME; McHutchison, JG; Shermock, KM
      Cost-effectiveness of interferon alfa 2b and ribavirin in the treatment ofchronic hepatitis C - Reply

      HEPATOLOGY
    19. Duchini, A; Younossi, ZM; Saven, A; Bordin, GM; Knowles, HJ; Pockros, PJ
      An open-label pilot trial of cladibrine (2-chlorodeoxyadenosine) in patients with primary sclerosing cholangitis

      JOURNAL OF CLINICAL GASTROENTEROLOGY
    20. Sarbah, SA; Younossi, ZM
      Hepatitis C: An update on the silent epidemic (vol 31, pg 125, 2000)

      JOURNAL OF CLINICAL GASTROENTEROLOGY
    21. Sarbah, SA; Younossi, ZM
      Hepatitis C - An update on the silent epidemic

      JOURNAL OF CLINICAL GASTROENTEROLOGY
    22. Ong, JP; Sands, M; Younossi, ZM
      Transjugular intrahepatic portosystemic shunts (TIPS) - A decade later

      JOURNAL OF CLINICAL GASTROENTEROLOGY
    23. Younossi, ZM; Kiwi, ML; Boparai, N; Price, LL; Guyatt, G
      Cholestatic liver diseases and health-related quality of life

      AMERICAN JOURNAL OF GASTROENTEROLOGY
    24. Matteoni, CA; Younossi, ZM
      Q: In diagnosing hepatitis C, which patient needs which test?

      CLEVELAND CLINIC JOURNAL OF MEDICINE
    25. Younossi, ZM; Perrillo, RP
      The roles of amantadine, rimantadine, ursodeoxycholic acid, and NSAIDs, alone or in combination with alpha interferons, in the treatment of chronic hepatitis C

      SEMINARS IN LIVER DISEASE
    26. Ong, JP; Barnes, DS; Younossi, ZM; Gramlich, T; Yen-Lieberman, B; Goormastic, M; Sheffield, C; Hoercher, K; Starling, R; Young, J; Smedira, N; McCarthy, P
      Outcome of de novo hepatitis C virus infection in heart transplant recipients

      HEPATOLOGY
    27. Younossi, ZM; Singer, ME; McHutchison, JG; Shermock, KM
      Cost effectiveness of interferon alpha 2b combined with ribavirin for the treatment of chronic hepatitis C

      HEPATOLOGY
    28. Younossi, ZM; Gramlich, T; Bacon, BR; Matteoni, CA; Boparai, N; O'Neill, R; McCullough, AJ
      Hepatic iron and nonalcoholic fatty liver disease

      HEPATOLOGY
    29. Younossi, ZM; Braun, WE; Protiva, DA; Gifford, RW; Straffon, RA
      Chronic viral hepatitis in renal transplant recipients with allografts functioning for more than 20 years

      TRANSPLANTATION
    30. Younossi, ZM; Guyatt, G; Kiwi, M; Boparai, N; King, D
      Development of a disease specific questionnaire to measure health related quality of life in patients with chronic liver disease

      GUT
    31. Matteoni, CA; Younossi, ZM; Gramlich, T; Boparai, N; Liu, YC; McCullough, AJ
      Nonalcoholic fatty liver disease: A spectrum of clinical and pathological severity

      GASTROENTEROLOGY
    32. Younossi, ZM; Boparai, N; Gramlich, T; Goldblum, J; George, P; Mayes, J
      Agreement in pathologic interpretation of liver biopsy specimens in posttransplant hepatitis C infection

      ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE
    33. Ong, J; Younossi, ZM
      Clinical predictors of large esophageal varices: How accurate are they?

      AMERICAN JOURNAL OF GASTROENTEROLOGY
    34. YOUNOSSI ZM; GRAMLICH T; LIU YC; MATTEONI C; PETRELLI M; GOLDBLUM J; RYBICKI L; MCCULLOUGH AJ
      NONALCOHOLIC FATTY LIVER-DISEASE - ASSESSMENT OF VARIABILITY IN PATHOLOGICAL INTERPRETATIONS

      Modern pathology
    35. YOUNOSSI ZM; CANUTO PE
      HEPATITIS-C UPDATE - IMPLICATIONS OF THE BLOOD-TRANSFUSION LOOKBACK

      Cleveland Clinic journal of medicine
    36. YOUNOSSI ZM
      EVALUATING ASYMPTOMATIC PATIENTS WITH MILDLY ELEVATED LIVER-ENZYMES

      Cleveland Clinic journal of medicine
    37. YOUNOSSI ZM; MULLEN KD; ZAKKO W; BRANDT E; HODNICK S; EASLEY K; BARNES D; CAREY WD; MCCULLOUGH AJ
      INTERFERON-ALPHA-2B AND RIBAVIRIN VS INTERFERON-ALPHA-2B AND AMANTADINE FOR CHRONIC HEPATITIS-C (NONRESPONDER) - A MULTICENTER, RANDOMIZED,DOUBLE-BLIND TRIAL

      Hepatology
    38. YOUNOSSI ZM; MATTEONI CA; GRAMLICH T; BOPARAI N; WOHL D; MCCULLOUGH AJ
      PATIENT CHARACTERISTICS PREDICTING CIRRHOSIS AND DEATH IN NONALCOHOLIC STEATOHEPATITIS

      Hepatology
    39. YOUNOSSI ZM; BOPURAI N; KIWI ML; MCCORMICK M; GUYATT G
      EXTENSIVE EVALUATION OF QUALITY-OF-LIFE (QOL) IN A LARGE COHORT OF PATIENTS WITH A VARIETY OF CHRONIC LIVER-DISEASES

      Hepatology
    40. HADZIYANNIS E; YOUNOSSI ZM; KIWI M; HODNICK S; STARKEY C; YENLIEBERMAN B
      COMPARISON OF 2 PCR-BASED METHODS FOR THE QUANTITATION OF HEPATITIS-CVIRUS-RNA

      Hepatology
    41. YOUNOSSI ZM; KIWI ML; MCCORMICK M; BOPARAI N; GUYATT G
      PERFORMANCE OF NEW DISEASE-SPECIFIC QUALITY-OF-LIFE INSTRUMENT IN CHOLESTATIC LIVER-DISEASE

      Hepatology
    42. MATTEONI CA; YOUNOSSI ZM; GRAMLICH TG; LIU Y; BOPARAI N; WOHL D; MCCULLOUGH AJ
      HISTOLOGIC IRON IS NOT INCREASED IN NONALCOHOLIC STEATOHEPATITIS

      Hepatology
    43. YOUNOSSI ZM; BOPARAI N; KIWI ML; FARQUHAR L; MCCORMICK M; GUYAU G
      CAN QUALITY-OF-LIFE PREDICT RESOURCE UTILIZATION IN LIVER-TRANSPLANT CANDIDATES

      Hepatology
    44. YOUNOSSI ZM; MCHUTCHISON JG; BROUSSARD C; CLOUTIER D; SEDGHIVAZIRI A
      PORTAL DECOMPRESSION BY TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNTAND CHANGES IN SERUM-ASCITES ALBUMIN GRADIENT

      Journal of clinical gastroenterology
    45. YOUNOSSI ZM; TERAN JC; GANIATS TG; CAREY WD
      ULTRASOUND-GUIDED LIVER-BIOPSY FOR PARENCHYMAL LIVER-DISEASE - AN ECONOMIC-ANALYSIS

      Digestive diseases and sciences
    46. KIWI ML; VAEZI MF; YOUNOSSI ZM; SINGER ME
      TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT VS. PLEURODESIS FOR TREATMENT OF SYMPTOMATIC HEPATIC HYDROTHORAX - A DECISION-ANALYSIS

      Gastroenterology
    47. MATTEONI CA; YOUNOSSI ZM; GRAMLICH T; LIU Y; RYBICKI L; MCCULLOUGH AJ
      NONALCOHOLIC FATTY LIVER-DISEASE - RISK-FACTORS AND LONG-TERM OUTCOMES FOR BENIGN VERSUS AGGRESSIVE DISEASE

      Gastroenterology
    48. YOUNOSSI ZM; KIWI ML; SECIC M; GUYATT G
      PROFOUND REDUCTION IN HEALTH-RELATED QUALITY-OF-LIFE IN PATIENTS WITHCHRONIC LIVER-DISEASE

      Gastroenterology
    49. ONEIL MM; YOUNOSSI ZM; LEE K; KIWI M; LARIVE B; CALABRESE LH
      EPIDEMIOLOGY OF RHEUMATIC SYMPTOMATOLOGY IN PATIENTS INFECTED WITH HEPATITIS-C VIRUS - RELATIONSHIP TO LIVER-DISEASE AND IMMUNE-RESPONSE

      Arthritis and rheumatism
    50. YOUNOSSI ZM; GUYATT G
      QUALITY-OF-LIFE ASSESSMENTS AND CHRONIC LIVER-DISEASE

      The American journal of gastroenterology
    51. YOUNOSSI ZM
      CHRONIC HEPATITIS-C - A CLINICAL OVERVIEW

      Cleveland Clinic journal of medicine
    52. YOUNOSSI ZM; KIWI M; KING D; GUYATT G
      A LIVER DISEASE-SPECIFIC HEALTH-RELATED QUALITY-OF-LIFE INDEX - CHRONIC LIVER-DISEASE QUESTIONNAIRE (CLDQ)

      Hepatology
    53. YOUNOSSI ZM; GRAMLICH T; LIU G; PETTRELLI M; GOLDBLUM J; RYBICKI L; MATTEONI C; MCCULLOUGH AC
      ASSESSMENT OF OBSERVER VARIABILITY ON PATHOLOGICAL INTERPRETATIONS OFNONALCOHOLIC STEATOHEPATITIS

      Hepatology
    54. YOUNOSSI ZM; MCHUTCHISON JG; GANIATS TG
      AN ECONOMIC-ANALYSIS OF NORFLOXACIN PROPHYLAXIS AGAINST SPONTANEOUS BACTERIAL PERITONITIS

      Journal of hepatology
    55. YOUNOSSI ZM; STRUM WB; SCHATZ RA; TEIRSTEIN PS; CLOUTIER DA; SPINKS TJ
      EFFECT OF COMBINED ANTICOAGULATION AND LOW-DOSE ASPIRIN TREATMENT ON UPPER GASTROINTESTINAL-BLEEDING

      Digestive diseases and sciences
    56. YOUNOSSI ZM; POCKROS PJ
      SYMPTOMATIC PORPHYRIA-CUTANEA-TARDA AND B-IMMUNOBLASTIC LYMPHOMA - ISTHERE AN ASSOCIATION

      American journal of hematology
    57. POCKROS PJ; YOUNOSSI ZM; WILKES LB; SAVEN A
      AN OPEN-LABEL PILOT-STUDY OF 2-CHLORODEOXYADENOSINE (2-CDA) IN THE TREATMENT OF EARLY-STAGE PRIMARY SCLEROSING CHOLANGITIS (PSC)

      Hepatology
    58. YOUNOSSI ZM; MCHUTCHISON JG; SEDGHIVAZIRI A; BROUSSARD CN
      CHANGES IN THE SERUM-ASCITES ALBUMIN GRADIENT FOLLOWING TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT

      Hepatology
    59. TERAN JC; YOUNOSSI ZM; CAREY WD
      COST-EFFECTIVENESS OF ULTRASOUND-GUIDED LIVER-BIOPSY FOR DIFFUSE PARENCHYMAL LIVER-DISEASE

      Gastroenterology
    60. YOUNOSSI ZM; MCHUTCHISON JG
      IS NORFLOXACIN PROPHYLAXIS AGAINST SBP COST-EFFECTIVE - AN ECONOMIC-ANALYSIS

      Hepatology
    61. YOUNOSSI ZM; FOROOZAN P
      TREATMENT OF CRIGLER-NAJJAR TYPE-II WITH SMALL-DOSE PHENOBARBITAL

      Digestive diseases and sciences
    62. YOUNOSSI ZM; STRUM WB; CLOUTIER D; TEIRSTEIN PS; SCHATZ RA
      UPPER GI BLEEDING IN POSTCORONARY STENT PATIENTS FOLLOWING ASPIRIN AND ANTICOAGULANT TREATMENT

      Gastroenterology
    63. YOUNOSSI ZM; BYLUND D; WILKES LB; MCHUTCHISON JG
      ANTI-LKM ANTIBODY AS A PREDICTOR OF RESPONSE TO ALPHA-INTERFERON IN CHRONIC HEPATITIS-C

      Hepatology


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 21/10/20 alle ore 15:30:42